Company Filing History:
1 out of 6 
1 out of 3 Years Active: 2015-2018
Title: Michael Gotthardt: Innovator in Cardiac Medicine
Introduction
Michael Gotthardt is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of cardiac medicine, particularly through his innovative patents. With a total of 2 patents, Gotthardt's work focuses on treating heart diseases and advancing medical research.
Latest Patents
One of his latest patents is a method for treating heart disease by inhibiting the Coxsackievirus-Adenovirus Receptor. This invention pertains to a means for downregulating or inhibiting or mislocalizing CAR in a cardiac cell for treating or curing a patient who has suffered or is predisposed to suffering a myocardial infarction (MI) or preventing myocardial infarction or complications thereof. Another significant patent involves polynucleotides for use in medicine. This invention refers to polynucleotides selected from the group consisting of a) polynucleotides encoding for the polypeptide RBM20 comprising a P638L mutation for a human polypeptide RBM20, or a P641L mutation for a rat polypeptide RBM20, b) polynucleotides with a reverse complementary sequence of the polynucleotide of a) above, and c) polynucleotides with an identity of at least 50% to a polynucleotide of a) or b) above.
Career Highlights
Throughout his career, Michael Gotthardt has worked with esteemed institutions such as the Max Delbrück Center for Molecular Medicine in Berlin-Buch. His research has significantly impacted the understanding and treatment of cardiac conditions.
Collaborations
He has collaborated with notable colleagues, including Fabian Freiberg and Norbert Hübner, contributing to advancements in medical research and innovation.
Conclusion
Michael Gotthardt's contributions to cardiac medicine through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for new treatments and understanding of heart diseases.